Examining the Biological Factors That Affect Sleep Duration

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00607204
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH), National Center for Research Resources (NCRR) (NIH)
119
1
73
1.6

Study Details

Study Description

Brief Summary

Sleep is necessary for healthy functioning, and people who sleep too little or too much may have an increased risk of developing health problems. This study will examine people who regularly sleep for short or long amounts of time to understand the biological factors that determine how much sleep a person needs.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The amount of sleep people require depends on many factors, including age, but experts agree that most adults need 7 to 8 hours of sleep a night. People who sleep for shorter or longer amounts of time may be at risk of developing memory problems, heart disease, obesity, and diabetes. The duration and timing of sleep are regulated by an interaction between the circadian pacemaker, or biological clock, and the sleep homeostat, which is an internal account of the amount of sleep a person has received recently. It is unknown whether there is a biological or genetic basis for the amount of sleep a person needs. This inpatient study will examine two extreme sleep groups: short sleepers who sleep 6.5 or less hours a night and long sleepers who sleep 9 or more hours a night. Participants will be exposed to identical sleep opportunities and living conditions. Using hormone analysis to examine participants' circadian rhythms, researchers will evaluate the biological differences that people undergo during the sleep process. Results from this study may help researchers understand whether sleep duration and sleep needs differ among people because of biological and genetic variations.

    Over a period of 4 to 6 weeks, potential study participants will attend 4 to 6 screening visits, which will include a medical history review, physical exam, blood and urine collection, electrocardiogram (EKG) to measure electrical activity of the heart, a psychological assessment, and an overnight stay in a sleep laboratory. For 3 weeks, potential participants will also wear an activity monitor, and they will record sleep habits electronically and in a daily diary.

    Participants who are eligible for the study will spend 28 days in the Intensive Physiological Monitoring Unit of the Clinical and Translational Sciences Center at the Brigham and Women's Hospital. Participants will not have access to a clock, radio, television, or computer, and they will not be allowed any outside contact. Most days participants will remain in bed for 10 to 14 hours; however, at selected times during the study, participants will remain inactive for periods of 32 to 64 hours and will stay awake for 32 to 40 hours. Throughout the study, participants' sleep patterns will be monitored continuously by a wrist activity recorder. Heart rhythms, brain electrical activity, eye movements, and temperature will also be measured continuously. At different times throughout the study, participants will undergo urine, saliva, and blood collection; alertness, mood, and performance evaluations; and blood pressure measurements. Upon release from the research center, participants will maintain a sleep diary for 3 weeks.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    119 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Neurobiology of Individual Differences in Sleep Duration
    Study Start Date :
    Oct 1, 2005
    Actual Primary Completion Date :
    Nov 1, 2011
    Actual Study Completion Date :
    Nov 1, 2011

    Outcome Measures

    Primary Outcome Measures

    1. Circadian rhythm assessment based on plasma melatonin and other hormones; sleep and EEG analysis; measurements of cognitive performance, alertness, and mood [Measured during the 4-week inpatient stay]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 35 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Routinely sleeps 6.5 hours or less a night, or routinely sleeps 9 hours or more a night

    • In good health

    Exclusion Criteria:
    • Diagnosed with a sleep disorder

    • Currently uses medications

    • Performed night shift work in the 3 years before study entry

    • History of psychiatric illness

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Brigham & Women's Hospital Boston Massachusetts United States 02115

    Sponsors and Collaborators

    • Brigham and Women's Hospital
    • National Heart, Lung, and Blood Institute (NHLBI)
    • National Center for Research Resources (NCRR)

    Investigators

    • Principal Investigator: Daniel Aeschbach, PhD, Brigham & Women's Hospital, Boston, MA

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Daniel Aeschbach, Associate Neuroscientist, Brigham and Women's Hospital
    ClinicalTrials.gov Identifier:
    NCT00607204
    Other Study ID Numbers:
    • 559
    • R01HL077399
    First Posted:
    Feb 5, 2008
    Last Update Posted:
    Jul 31, 2013
    Last Verified:
    Jul 1, 2013
    Keywords provided by Daniel Aeschbach, Associate Neuroscientist, Brigham and Women's Hospital

    Study Results

    No Results Posted as of Jul 31, 2013